Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4970511019 | Product containing alogliptin and pioglitazone in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4970512014 | Alogliptin- and pioglitazone-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Alogliptin- and pioglitazone-containing product in oral dose form | Is a | Alogliptin- and pioglitazone-containing product | true | Inferred relationship | Some | ||
Alogliptin- and pioglitazone-containing product in oral dose form | Is a | Alogliptin-containing product in oral dose form | true | Inferred relationship | Some | ||
Alogliptin- and pioglitazone-containing product in oral dose form | Is a | Pioglitazone-containing product in oral dose form | true | Inferred relationship | Some | ||
Alogliptin- and pioglitazone-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Alogliptin- and pioglitazone-containing product in oral dose form | Has active ingredient | Pioglitazone | true | Inferred relationship | Some | 1 | |
Alogliptin- and pioglitazone-containing product in oral dose form | Has active ingredient | Alogliptin | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Alogliptin and pioglitazone only product in oral dose form | Is a | True | Alogliptin- and pioglitazone-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set